Ocean Bio-Chem, Inc. (OBCI) Reaches $4.19 After 4.00% Down Move; Hemispherx Biopharma (NYSEAMERICAN:HEB) Shorts Increased By 3.76%

November 14, 2017 - By Ruchi Gupta

Hemispherx Biopharma Incorporated (NYSEAMERICAN:HEB) had an increase of 3.76% in short interest. HEB’s SI was 1.08 million shares in November as released by FINRA. Its up 3.76% from 1.04 million shares previously. With 150,600 avg volume, 7 days are for Hemispherx Biopharma Incorporated (NYSEAMERICAN:HEB)’s short sellers to cover HEB’s short positions. The SI to Hemispherx Biopharma Incorporated’s float is 4.49%. About 230,259 shares traded. Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB) has declined 60.74% since November 14, 2016 and is downtrending. It has underperformed by 77.44% the S&P500.

The stock of Ocean Bio-Chem, Inc. (NASDAQ:OBCI) is a huge mover today! About 63,426 shares traded or 137.93% up from the average. Ocean Bio-Chem, Inc. (NASDAQ:OBCI) has risen 96.36% since November 14, 2016 and is uptrending. It has outperformed by 79.66% the S&P500.The move comes after 9 months negative chart setup for the $38.62M company. It was reported on Nov, 14 by Barchart.com. We have $4.02 PT which if reached, will make NASDAQ:OBCI worth $1.54M less.

Hemispherx Biopharma, Inc. is a specialty pharmaceutical company. The company has market cap of $9.66 million. The Firm is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. It currently has negative earnings. The Company’s segment is engaged in research and development activities related to Ampligen and other drugs under development, and sales and marketing of Alferon.

Investors sentiment increased to 3 in Q2 2017. Its up 2.33, from 0.67 in 2017Q1. It improved, as 0 investors sold Ocean Bio-Chem, Inc. shares while 2 reduced holdings. 1 funds opened positions while 5 raised stakes. 223,136 shares or 19.99% more from 185,956 shares in 2017Q1 were reported. California Public Employees Retirement invested in 31,895 shares. Morgan Stanley reported 0% of its portfolio in Ocean Bio-Chem, Inc. (NASDAQ:OBCI). Renaissance Technology Ltd Co owns 31,600 shares. Grt Capital Prns Ltd holds 0.05% or 19,874 shares. Geode Limited Company holds 0% of its portfolio in Ocean Bio-Chem, Inc. (NASDAQ:OBCI) for 26,292 shares. James Investment Research Inc holds 11,125 shares or 0% of its portfolio. The Germany-based Deutsche Bancorporation Ag has invested 0% in Ocean Bio-Chem, Inc. (NASDAQ:OBCI). Panagora Asset Mngmt holds 0% or 13,225 shares. Blackrock holds 0% or 6,125 shares in its portfolio. Dimensional Fund Advsr Lp invested in 0% or 11,757 shares. Essex Management Ltd Company holds 0.02% or 34,997 shares in its portfolio. Vanguard Group Incorporated has 24,605 shares.

Ocean Bio-Chem, Inc. is engaged in the manufacturing, marketing and distribution of a range of appearance, performance and maintenance products. The company has market cap of $38.62 million. The Firm offers its services under the Star brite and Star Tron brand names within the United States and Canada. It has a 11.07 P/E ratio. In addition, the Company produces private label formulations of its products for various clients and provides custom blending and packaging services for these and other products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>